|
|
Post by magnus123 on Nov 12, 2020 18:56:44 GMT
Management totally killed this stock. But it looks cheap now, even with the dilution. Maybe a possibility for a nice jump?
|
|
|
|
Post by JHam on Nov 20, 2020 6:06:25 GMT
Management totally killed this stock. But it looks cheap now, even with the dilution. Maybe a possibility for a nice jump? I've been thinking about it, but not worth the risk for me while COVID cases are worse than ever and elective surgeries are on the back burner. |
|
|
|
Post by Yelk on Feb 7, 2021 18:51:57 GMT
Anything going on here? Looks like starting to get some legs wasnt sure if you guys still in here, was shocked to see it sub $1, really thought in this market could have been $10
|
|
|
|
Post by JHam on Feb 7, 2021 23:58:02 GMT
Anything going on here? Looks like starting to get some legs wasnt sure if you guys still in here, was shocked to see it sub $1, really thought in this market could have been $10 I haven’t followed this one for a while now. COVID slowed down their launch and the endless dilution turned me off. |
|
|
|
Post by magnus123 on Feb 8, 2021 12:09:21 GMT
Anything going on here? Looks like starting to get some legs wasnt sure if you guys still in here, was shocked to see it sub $1, really thought in this market could have been $10 A lot of small biotechs trading below $1 or a little bit higher have run hard the last days and weeks. I bought NSPR this morning for example. Baudax could be a nice trade opportunity as well in this category. |
|
